Inhibition of store-operated Ca2+ entry counteracts the apoptosis of nasopharyngeal carcinoma cells induced by sodium butyrate.

Sodium butyrate (NaBu), a histone deacetylase inhibitor, has demonstrated anti-tumor effects in several cancers, and is a promising candidate chemotherapeutic agent. However, its roles in nasopharyngeal carcinoma (NPC), an endemic malignant disease in Southern China and Southeast Asia, has rarely been studied. In the present study, MTT assay, colony formation assay, flow cytometry analysis and western blotting were performed to explore the influence of NaBu on NPC cells and its underlying mechanism. NaBu induced morphological changes and inhibited proliferation in 5-8F and 6-10B cells. MTT assay revealed that NaBu was cytotoxic to 5-8F and 6-10B cells in a dose- and time-dependent manner. Furthermore, flow cytometry analysis revealed that NaBu induced obvious cell apoptosis in 5-8F and 6-10B cells due to the activation of the mitochondrial apoptosis axis. In addition, flow cytometry analysis and western blotting demonstrated that NaBu could enhance the Ca2+ influx by promoting store-operated Ca2+ entry (SOCE) in 5-8F and 6-10B cells. Inhibition of SOCE by specific inhibitors or downregulated expression of calcium release-activated calcium channel protein 1 and stromal interaction molecule 1 could counteract the apoptosis of NPC cells induced by NaBu. Thus, the current study revealed that enhanced SOCE and activated mitochondrial apoptosis axis may account for the mechanisms of cytotoxicity of NaBu in NPC cells, and that NaBu serves as a promising chemotherapeutic agent in NPC therapy.

[1]  L. Zeng,et al.  Promoter hypermethylation along with LOH, but not mutation, contributes to inactivation of DLC‐1 in nasopharyngeal carcinoma , 2014, Molecular carcinogenesis.

[2]  P. Tchounwou,et al.  Cisplatin in cancer therapy: molecular mechanisms of action. , 2014, European journal of pharmacology.

[3]  G. Lepage,et al.  Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma. , 2014, Biochimica et biophysica acta.

[4]  R. Johnstone,et al.  Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders , 2015, Nature Reviews Drug Discovery.

[5]  C. Stournaras,et al.  Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells , 2014, Oncotarget.

[6]  R. Singh,et al.  Sodium butyrate induces DRP1-mediated mitochondrial fusion and apoptosis in human colorectal cancer cells. , 2014, Mitochondrion.

[7]  N. Prevarskaya,et al.  Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks? , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[8]  R. Johnstone,et al.  New and emerging HDAC inhibitors for cancer treatment. , 2014, The Journal of clinical investigation.

[9]  I. Tan,et al.  Current Treatment Options for Local Residual Nasopharyngeal Carcinoma , 2013, Current Treatment Options in Oncology.

[10]  Pedro Gonçalves,et al.  Butyrate and colorectal cancer: the role of butyrate transport. , 2013, Current drug metabolism.

[11]  Jun Du,et al.  Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells. , 2013, Life sciences.

[12]  Zhuo Gao,et al.  Sodium Butyrate Induces Growth Inhibition and Apoptosis in Human Prostate Cancer DU145 Cells by Up-Regulation of the Expression of Annexin A1 , 2013, PloS one.

[13]  Z. Kolár̂,et al.  Different effect of sodium butyrate on cancer and normal prostate cells. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  K. Yao,et al.  DLC-1, a candidate tumor suppressor gene, inhibits the proliferation, migration and tumorigenicity of human nasopharyngeal carcinoma cells. , 2013, International journal of oncology.

[15]  Yan Li,et al.  Gypenosides induce apoptosis by ca2+ overload mediated by endoplasmic-reticulum and store-operated ca2+ channels in human hepatoma cells. , 2013, Cancer biotherapy & radiopharmaceuticals.

[16]  W. Chiu,et al.  Remodeling of calcium signaling in tumor progression , 2013, Journal of Biomedical Science.

[17]  S. Feske,et al.  Emerging roles of store-operated Ca2+ entry through STIM and ORAI proteins in immunity, hemostasis and cancer , 2013, Channels.

[18]  G. Betts,et al.  Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[19]  N. Prevarskaya,et al.  Targeting Ca2+ transport in cancer: close reality or long perspective? , 2013, Expert opinion on therapeutic targets.

[20]  H. Mai,et al.  Emerging treatment options for nasopharyngeal carcinoma , 2013, Drug design, development and therapy.

[21]  丸山 琢雄.  Apoptosis of bladder cancer by sodium butyrate and cisplatin , 2013 .

[22]  B. Anachkova,et al.  The Inhibitor of Histone Deacetylases Sodium Butyrate Enhances the Cytotoxicity of Mitomycin C , 2012, Molecular Cancer Therapeutics.

[23]  Longying Zha,et al.  Requirement for store-operated calcium entry in sodium butyrate-induced apoptosis in human colon cancer cells. , 2012, Bioscience reports.

[24]  R. Liu,et al.  c-MET Protects Breast Cancer Cells from Apoptosis Induced by Sodium Butyrate , 2012, PloS one.

[25]  C. Qian,et al.  The prevalence and prevention of nasopharyngeal carcinoma in China , 2011, Chinese journal of cancer.

[26]  C. Romanin,et al.  Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells , 2010, Cell Death and Disease.

[27]  Xin-Yun Huang,et al.  Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. , 2009, Cancer cell.

[28]  D. Chang,et al.  Calcium and Apoptosis , 2009 .

[29]  P. Pinton,et al.  Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis , 2008, Oncogene.

[30]  M. Tang,et al.  Soft substrate upregulates the interaction of STIM 1 with store-operated Ca 2 + channels that leads to normal epithelial cell apoptosis , 2008 .

[31]  W. Weichert,et al.  Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo , 2008, Clinical Cancer Research.

[32]  W. Weichert,et al.  Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy , 2008, British Journal of Cancer.

[33]  Qing‐Li Zhao,et al.  Enhancement of sodium butyrate-induced cell death and apoptosis by X-irradiation in the human colorectal cancer cell line HCT 116. , 2008, Oncology reports.

[34]  H. M. Beier,et al.  Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis , 2005, Breast Cancer Research and Treatment.

[35]  D. Ferrari,et al.  Calcium and apoptosis: facts and hypotheses , 2003, Oncogene.

[36]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.